Celldex Therapeutics, Inc. Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31)
Celldex Therapeutics, Inc. (CLDX) had Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) of $211.41 million as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost · last filed 2014-08-07
- 2014-06-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $211.41M.
- 2014-03-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $217.24M.
- 2013-12-31: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $133.50M.
- 2013-09-30: Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) $121.86M.
| Period end | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) |
|---|---|
| 2014-06-30 | $211.41M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $217.24M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $133.50M 10-Q · filed 2014-08-07 |
| 2013-09-30 | $121.86M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $129.12M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $106.65M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $58.91M 10-K · filed 2014-03-03 |
| 2012-09-30 | $54.24M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $59.98M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $41.35M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |